Klorzoxazon Evolan (Chlorzoxazone)

Chlorzoxazone works by centrally inhibiting polysynaptic reflex pathways in the spinal cord. This action reduces the transmission of excitatory signals to skeletal muscles, decreasing muscle tone and spasm without directly acting on the muscle fibers themselves, thereby providing relief from painful contractions.

The appropriate dose of Klorzoxazon Evolan is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Dosage adjustments may be needed for renal or hepatic impairment, and the prescriber will provide specific instructions.

Safety data for chlorzoxazone during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers typically advise caution and may recommend alternative therapies when possible.

To order Klorzoxazon Evolan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Klorzoxazon Evolan (chlorzoxazone) differs from alternatives such as cyclobenzaprine or tizanidine in its mechanism and side‑effect profile. Chlorzoxazone acts centrally on spinal reflexes, whereas cyclobenzaprine primarily affects the brainstem. Tizanidine is an alpha‑2 agonist with a higher risk of hypotension. Choice of agent depends on patient tolerance, comorbidities, and physician preference.

Store Klorzoxazon Evolan at ambient temperature below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity, which could affect its stability.

Klorzoxazon Evolan is administered orally, typically as a tablet taken with or without food as directed by the prescriber. The exact timing and whether it should be taken with meals depend on individual patient instructions and tolerability.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity leading to elevated liver enzymes or liver failure, blood dyscrasias like agranulocytosis, and rare cases of anaphylaxis. Patients should be monitored for signs of these reactions and seek immediate medical attention if they occur.

Klorzoxazon Evolan is contraindicated in patients with known hypersensitivity to chlorzoxazone or any of its excipients. It should also be avoided in individuals with severe hepatic impairment, uncontrolled epilepsy, or those taking certain contraindicated CNS depressants without medical supervision.